Pfizer Forecasts $33.5 Billion in Covid-19 Vaccine Sales

Company raises full-year outlook as it prepares to ask U.S. regulators to authorize booster shots 6 min video: https://www.wsj.com/e996861f-1eb2-4217-a10a-8421a72e8c1d By Jared S. Hopkins and Matt Grossman July 28, 2021 Listen to article Length2 minutes Pfizer Inc. expects sales for its Covid-19 vaccine this year to reach about $33.5 billion, up nearly 30% from its forecast three months ago,